CoverageForm 410-K10-Q8-K13D13G13F

EMMA Emmaus Life Sciences, Inc. - 8-K

Filed Apr 14, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-043577
5.029.01

Item 5.02 - Departure/Election of Directors or Certain Officers

42 words

Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers

Resignation of Director

On April 13, 2026, Jon Kuwahara resigned as a director
of Emmaus Life Sciences, Inc., effective April 15, 2026.

Item 9.01 - Financial Statements and Exhibits

24 words

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Number

Description

104

Cover Page Interactive Data File (embedded within the inline XBRL Document)

1